Collaborative Medicinal Development Overview
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$712K
- Investors
-
2
Collaborative Medicinal Development General Information
Description
Operator of a biopharmaceutical company intended to develop novel disease-modifying drugs for the treatment of both neurodegenerative diseases and cancer. The company's services include research and development of anti-amyloid small molecules that identify toxins using advanced protein chemistry methods, enabling healthcare professionals to avail drugs for the treatment of unmet medical conditions.
Contact Information
Website
www.colmeddev.comCorporate Office
- 100 Shoreline Highway
- Suite B280
- Mill Valley, CA 94941
- United States
Corporate Office
- 100 Shoreline Highway
- Suite B280
- Mill Valley, CA 94941
- United States
Collaborative Medicinal Development Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 17-Apr-2019 | $712K | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC | Completed | Startup |
Collaborative Medicinal Development Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Collaborative Medicinal Development Patents
Collaborative Medicinal Development Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230172940-A1 | Methods of extending lifespan by administering ferroptosis inhibitors | Pending | 21-Jul-2020 | ||
| WO-2022020150-A1 | Methods of extending lifespan by administering ferroptosis inhibitors | Inactive | 21-Jul-2020 | ||
| AU-2020234788-A1 | Heteroaromatic and heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders | Active | 11-Mar-2019 | ||
| AU-2020234788-B2 | Heteroaromatic and heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders | Active | 11-Mar-2019 | ||
| CA-3133070-A1 | Heteroaromatic and heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders | Pending | 11-Mar-2019 | C07D239/48 |
Collaborative Medicinal Development Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Collaborative Medicinal Development Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FightMND | Corporation | |||
| Cthulhu Ventures | Venture Capital | Minority |
Collaborative Medicinal Development FAQs
-
Where is Collaborative Medicinal Development headquartered?
Collaborative Medicinal Development is headquartered in Mill Valley, CA.
-
What is the size of Collaborative Medicinal Development?
Collaborative Medicinal Development has 2 total employees.
-
What industry is Collaborative Medicinal Development in?
Collaborative Medicinal Development’s primary industry is Drug Discovery.
-
Is Collaborative Medicinal Development a private or public company?
Collaborative Medicinal Development is a Private company.
-
What is Collaborative Medicinal Development’s current revenue?
The current revenue for Collaborative Medicinal Development is .
-
Who are Collaborative Medicinal Development’s investors?
FightMND and Cthulhu Ventures have invested in Collaborative Medicinal Development.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
